BECTON, DICKINSON AND COMPANY Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent
BECTON, DICKINSON AND COMPANY (BDX) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent of -$82.07 million for the 12-month period ending 2009-09-30, per its 10-K/A filed 2010-01-21.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent · last filed 2010-01-21
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2009 was -$82.07M, a 287.08% decline from fiscal 2008.
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2008 was $43.87M.
- BECTON, DICKINSON AND COMPANY other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2007 was -$2.60M.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 12 month |
|---|---|
| 2009-09-30 | -$82.07M 10-K/A · filed 2010-01-21 |
| 2008-09-30 | $43.87M 10-K/A · filed 2010-01-21 |
| 2007-09-30 | -$2.60M 10-K/A · filed 2010-01-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |